Foundation of InnovaCare Health by CEO Rick Shinto

InnovaCare Health was founded in 1998 by CEO and President Richard Shinto. This was when he joined NAMM- North American Medical Management in California. He noticed a gap in operational skills among physicians and payers. He, therefore, worked with NAMM to assist healthcare providers in offering quality care more effectively.

Leadership

Dr. Shinto is the CEO and President of InnovaCare subsidiaries through MMM Holdings. This includes MMM Healthcare; the leading Medicare Advantage plan which manages more than 250,000 people in Puerto Rico. Before joining NAMM, he was the CMO and COO for Medical Pathways Management Company. In 1995 to 1997, he served in MedPartners as the Vice President of Medical Management.

Penelope Kokkinides serves as Chief Administrative Officer at InnovaCare Health since June 2015. Formerly she served as COO of InnovaCare and Aveta Inc. and Vice President of Clinical Operations. Before rejoining InnovaCare, she served as COO and Executive Vice President for Centerlight HealthCare.

Awards won by Dr. Rick Shinto

He has won many awards for his outstanding achievements in the medical field and leadership skills. They include:

 

  • Access to Caring Award

 

  • 2018’s Top 25 Minority Executives in Healthcare Award

 

  • Ernst & Young Entrepreneur Of The Year Award-2012

 

InnovaCare Health Approach

InnovaCare Inc. is a major provider of managed healthcare services in N. America. It offers these services through two main avenues; Medicare Advantage and Provider Networks. Their main focus is to provide quality healthcare through advanced technology, sustainable models which are cost-effective & fully integrated.

Puerto Rico was devastated by Hurricane Maria in 2017. InnovaCare Health was very instrumental in restoring healthcare services on the island. The company is dedicated to promoting health equity, especially to the vulnerable patients. Due to the company’s centric model, its healthcare plans have received NCQA accreditation. It’s the only company in Puerto Rico with 4.5-star rating from CMS- Centers for Medicare and Medicaid Services.

A team of healthcare experts leads InnovaCare Health. The leaders have many years of combined experience in care delivery and managed care. Therefore, they can effectively help healthcare providers to meet the rising demands of this industry. This integrated model has promoted patient care and supported physician’s resources.

Conclusion

InnovaCare Health has changed many lives by offering affordable healthcare to all. The leadership team has played a major role in implementing their integrated model. This has brought a great breakthrough in the healthcare industry which is facing financial pressure every day.

http://innovacarehealth.com/

“Marc Beer: A Driving Force behind the Success of Renovia “

The article entitled “Renovia Completes $42.3 Million Series B Financing” is an exciting new development in the field of medicine. Renovia is a medical device and diagnostic company that was founded in 2016 by Marc Beer and Ramon Iglesias. The purpose of the company was to work hard and find ways to help alleviate pelvic floor disorders that can cause ailments like incontinence in women. They are providing a valuable service to countless women all over the world by taking the time to look into this growing problem. In fact, according to this article Renovia has taken the first steps into securing funding for their next leg of research.

 

In addition to doing research on pelvic floor disorders, Renovia is also responsible for the production of medical devices that hope to alleviate some of the symptoms that women experience with this disorder. The company is responsible for offering both diagnostic and therapeutic devices that will assist women as they struggle with pelvic floor disorders. Renovia’s pursuit of funding is one of the ways that they hope to expand their development of these devices. Renovia relies on the committed leaders that had up their company to parlay their sense of passion into the projects that they oversee. Without leaders like Marc Beer, they would be less effective for the women that they help every single day.

 

Marc Beer is an exceptional part of the development process for Renovia. He is often credited with his initial efforts to get Renovia up off the ground and developed. In fact, he is one of the main reasons why the company started to begin with. He exercised a degree of tenacity that is only seen the best businessmen. Through his efforts, he raised more than $42 million to fund the woman’s health company. The company has now become a major part of the development of pelvic floor disorder equipment. Marc Beer believed that Renovia needed to expand to help the growing population that was affected by this disorder.

 

Marc Beer is a businessman with more than 25 years in the development and commercialization industry for biotechnology. He has developed much of his career alongside his knowledge of pharmaceuticals, diagnostics, and device creation. Many of his previous roles helped prepare him for the growth he would need to successfully lead Renovia. He has operated as a founder for various biotechnology companies all specializing in some of the most interesting technological advancements. He obtained a degree from Miami University located in Ohio which adds to his knowledge in his field and his ability to comprehend the material. He has taken up the vigil of Renovia in order to help countless women. His work will continue to touch the lives of many people. Learn more: https://www.slideshare.net/MarcBeer

 

Marc Beer – article recap

Marc Beer For Women’s Health

 

Renowned CEO Marc Beer recently made headlines recently when his new corporation Renovia announced they are pushing forward with the release of several new products of pelvic floor disorder products to help with women’s health. The funding comes from a Series B round which closed with an amount of $32 million in addition to venture debt totaling $10 million.

 

The newly-formed company is focused on developing such products as diagnostic and therapeutic products to aid in the relief of urinary incontinence. Researchers in the United States estimate that this particular medical disorder plagues 250 million women all over the world. The first product, which goes by the name of Leva, was approved by the FDA back in April. This is obviously the first product to hit the market, but certainly no the first.

 

Beer partnered with a funding group known as the Longwood Fund to harness the capital. The Fund has long been interested in searching out for new and novel ways to produce cutting-edge medical treatments, With this level of funding, Beer hopes to introduce 4 more treatment methods and devices to the market soon, as well as a new generation of the already released Leva.

 

This should not surprise anyone who has followed the career of Marc Beer. He has a wealth of experience he brings to the table include 25 years exclusively focusing on the biotechnology and pharmaceutical sectors of the marketplace. He is renowned throughout the medical investment community as an executive who is not afraid to take chances. He has exhibited an unusual knack for predicting what future demands in both consumer demand and medical needs entail.

 

Marc Beer stated he was quite excited with the new rollout and all that it entails as the new company not only gets to make a huge difference in women’s lives all over the world but gets to leverage some of their proprietary technology such as their digital platform and the form technology. All of this coincides with the recent announcements which, once again in the career of Marc Beer, had the world in awe. Learn more: https://www.slideshare.net/MarcBeer